AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship

Nominations for the 2009 Lectureship are now closed.  The recipient will be announced in January 2009.

Learn more about the 2008 recipient Dr. Nancy E. Davidson. View the list of all past winners.

The Lectureship

The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation, and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.

The winner will present a 50-minute Lectureship during the AACR 100th Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009), and receive an honorarium and commemorative plaque.

Eligibility

• Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
• The Lectureship will be presented to an individual investigator.
• Institutions or organizations are not eligible for the Lectureship.
  
  

Nomination Process

Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination letters must be sent electronically to awards@aacr.org by Thursday, October 30, 2008, at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:

• the name of the AACR Award for which the candidate is being nominated;
  
• a brief statement of no more than 50 words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;
  
• a concise description of the candidate's meritorious contributions to the field of cancer research, with the publications supporting these accomplishments directly referenced within the letter;
• a concise description of how the candidate has furthered the advancement of women in science through leadership or by example; and
• a concise description of the impact of these contributions on the field.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Selection

Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of women in science. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

The winner of the 12th Annual AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship will be announced in January 2009.

Sponsor

Generously supported by MedImmune.

Questions?

Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404